Sanofi Consumer Healthcare India Limited has informed the Exchange regarding 'Citigroup Global Markets India Pvt. Ltd. (Manager to the Offer) has submitted to the Exchange a copy of Disclosure in relation to number of Equity Shares tendered in connection with the Open Offer on May 09,2025'.
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.5 pts less than Nifty Microcap 250 and 2.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Citigroup Global Markets India, the Manager to the Offer, has disclosed the number of equity shares tendered in the ongoing open offer for Sanofi Consumer Healthcare India Limited. The acquirer, Opal Bidco SAS (along with Clayton, Dubilier & Rice Fund XII, L.P. as a person acting in concert), is seeking to buy up to 59,87,962 equity shares (26% of voting share capital) from public shareholders. As of May 9, 2025, a total of 25,04,630 shares have been tendered, representing 41.83% of the offer size. Of these, 52,054 shares were tendered on May 9 alone. The letter of offer was originally dated April 12, 2025, and acceptance is subject to document validation under SEBI Takeover Regulations.
The tendering is currently below the 26% offer size, indicating moderate but not overwhelming shareholder interest so far. Investors holding shares should monitor the final tender acceptance and settlement, as acceptance will follow SEBI validation rules and may differ from the tendered number.